Mutations in this key structural and functional element have been previously described in EGFR in non-small cell lung cancer, in BCR::ABL1 in CML, and in BRAF in colon cancer (60, 72, 73). Here, EGFR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.